Completed NA INTERVENTIONAL 1-arm NCT00561457

A Clinical Evaluation of the Bard® Luminexx™ Iliac Stent and Delivery System (Luminexx)

Sponsor: C. R. Bard

Conditions Iliac Artery Occlusive Disease

Interventions Bard Luminexx Iliac Stent and Delivery System

Updated 8 times since 2017 Last updated: Jan 17, 2017 Started: Jun 30, 2003 Primary completion: Jan 31, 2008 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Iliac Artery Occlusive Disease, this trial is completed. The trial is conducted by C. R. Bard and has accumulated 8 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

C. R. Bard

Data source: C. R. Bard

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.